Mant, Jonathan 
ORCID: 0000-0002-9531-0268, Modi, Rakesh N ORCID: 0000-0001-9651-6690, Charlton, Peter ORCID: 0000-0003-3836-8655, Dymond, Andrew ORCID: 0000-0003-0764-3095, Massou, Efthalia ORCID: 0000-0003-0488-482X, Brimicombe, James ORCID: 0000-0002-3443-3256, Freedman, Ben ORCID: 0000-0002-3809-2911, Griffin, Simon J ORCID: 0000-0002-2157-4797, Hobbs, FD Richard ORCID: 0000-0001-7976-7172, Lip, Gregory YH ORCID: 0000-0002-7566-1626 et al (show 2 more authors)
(2024)
The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devices.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26 (3).
euae056-.
Abstract
<h4>Aims</h4>There are few data on the feasibility of population screening for paroxysmal atrial fibrillation (AF) using hand-held electrocardiogram (ECG) devices outside a specialist setting or in people over the age of 75. We investigated the feasibility of screening when conducted without face-to-face contact ('remote') or via in-person appointments in primary care and explored impact of age on screening outcomes.<h4>Methods and results</h4>People aged ≥65 years from 13 general practices in England participated in screening during 2019-20. This involved attending a practice nurse appointment (10 practices) or receiving an ECG device by post (three practices). Participants were asked to use a hand-held ECG for 1-4 weeks. Screening outcomes included uptake, quality of ECGs, AF detection rates, and uptake of anticoagulation if AF was detected. Screening was carried out by 2141 (87.5%) of people invited to practice nurse-led screening and by 288 (90.0%) invited to remote screening. At least 56 interpretable ECGs were provided by 98.0% of participants who participated for 3 weeks, with no significant differences by setting or age, except people aged 85 or over (91.1%). Overall, 2.6% (64/2429) screened participants had AF, with detection rising with age (9.2% in people aged 85 or over). A total of 53/64 (82.8%) people with AF commenced anticoagulation. Uptake of anticoagulation did not vary by age.<h4>Conclusion</h4>Population screening for paroxysmal AF is feasible in general practice and without face-to-face contact for all ages over 64 years, including people aged 85 and over.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Humans, Atrial Fibrillation, Anticoagulants, Electrocardiography, Mass Screening, Feasibility Studies |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 09 Apr 2024 10:09 |
| Last Modified: | 09 Apr 2024 13:59 |
| DOI: | 10.1093/europace/euae056 |
| Open Access URL: | https://doi.org/10.1093/europace/euae056 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3180222 |
Dimensions
Dimensions
